Ontology highlight
ABSTRACT:
SUBMITTER: Ruella M
PROVIDER: S-EPMC6142482 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature
Hematology. American Society of Hematology. Education Program 20161201 1
Representative clinical case. A 74-year-old male patient was diagnosed with stage 3 mantle cell lymphoma in 2012. Because he was ineligible for intensive treatment (age, previous myocardial infarction [MI]), he received rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemoimmunotherapy for 6 cycles (reaching complete response) and then rituximab maintenance (RM) for 2 years. One year after the end of RM, he relapsed with disseminated disease. He was started on ...[more]